321 related articles for article (PubMed ID: 31464928)
1. Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
Matsuoka N; Kozuru H; Koga T; Abiru S; Yamasaki K; Komori A; Fujita Y; Tenmoku J; Asano T; Sato S; Suzuki E; Furuya M; Kobayashi H; Watanabe H; Naganuma A; Yoshizawa K; Shimada M; Ario K; Yamashita H; Kohno H; Kaneyoshi T; Nakamura M; Furukawa H; Takahashi A; Kawakami A; Ohira H; Yatsuhashi H; Migita K
Medicine (Baltimore); 2019 Aug; 98(35):e16924. PubMed ID: 31464928
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis.
Migita K; Horai Y; Kozuru H; Koga T; Abiru S; Yamasaki K; Komori A; Fujita Y; Asano T; Sato S; Suzuki E; Matsuoka N; Kobayashi H; Watanabe H; Naganuma A; Naeshiro N; Yoshizawa K; Ohta H; Sakai H; Shimada M; Nishimura H; Tomizawa M; Ario K; Yamashita H; Kamitsukasa H; Kohno H; Nakamura M; Furukawa H; Takahashi A; Kawakami A; Ohira H; Yastuhashi H
Medicine (Baltimore); 2018 Dec; 97(50):e13450. PubMed ID: 30557999
[TBL] [Abstract][Full Text] [Related]
3. Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
Migita K; Nakamura M; Aiba Y; Kozuru H; Abiru S; Komori A; Fujita Y; Temmoku J; Asano T; Sato S; Furuya M; Naganuma A; Yoshizawa K; Shimada M; Ario K; Mannami T; Kohno H; Kaneyoshi T; Komura T; Ohira H; Yatsuhashi H
PLoS One; 2020; 15(12):e0238540. PubMed ID: 33347507
[TBL] [Abstract][Full Text] [Related]
4. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.
Shirabe K; Bekki Y; Gantumur D; Araki K; Ishii N; Kuno A; Narimatsu H; Mizokami M
J Gastroenterol; 2018 Jul; 53(7):819-826. PubMed ID: 29318378
[TBL] [Abstract][Full Text] [Related]
5. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.
Mak LY; To WP; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
World J Gastroenterol; 2019 Mar; 25(11):1398-1408. PubMed ID: 30918432
[TBL] [Abstract][Full Text] [Related]
6. Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy.
Nagata H; Nakagawa M; Nishimura-Sakurai Y; Asano Y; Tsunoda T; Miyoshi M; Kaneko S; Goto F; Otani S; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Azuma S; Kakinuma S; Tojo N; Tohda S; Asahina Y; Watanabe M;
Hepatol Int; 2016 Nov; 10(6):956-964. PubMed ID: 27435935
[TBL] [Abstract][Full Text] [Related]
7. High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.
Shinkai N; Nojima M; Iio E; Matsunami K; Toyoda H; Murakami S; Inoue T; Ogawa S; Kumada T; Tanaka Y
J Gastroenterol; 2018 Jul; 53(7):883-889. PubMed ID: 29288305
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
Migita K; Komori A; Kozuru H; Jiuchi Y; Nakamura M; Yasunami M; Furukawa H; Abiru S; Yamasaki K; Nagaoka S; Hashimoto S; Bekki S; Kamitsukasa H; Nakamura Y; Ohta H; Shimada M; Takahashi H; Mita E; Hijioka T; Yamashita H; Kouno H; Nakamuta M; Ario K; Muro T; Sakai H; Sugi K; Nishimura H; Yoshizawa K; Sato T; Naganuma A; Komatsu T; Oohara Y; Makita F; Tomizawa M; Yatsuhashi H
PLoS One; 2015; 10(11):e0136908. PubMed ID: 26575387
[TBL] [Abstract][Full Text] [Related]
9. Serum galectin 3, galectin 9 and galectin 3-binding proteins in patients with active and inactive inflammatory bowel disease.
Cibor D; Szczeklik K; Brzozowski B; Mach T; Owczarek D
J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31019124
[TBL] [Abstract][Full Text] [Related]
10. Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B.
Hsu YC; Jun T; Huang YT; Yeh ML; Lee CL; Ogawa S; Cho SH; Lin JT; Yu ML; Nguyen MH; Tanaka Y
Aliment Pharmacol Ther; 2018 Nov; 48(10):1128-1137. PubMed ID: 30306612
[TBL] [Abstract][Full Text] [Related]
11. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
[TBL] [Abstract][Full Text] [Related]
13. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
[TBL] [Abstract][Full Text] [Related]
14. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.
Ahn SS; Park Y; Lee DD; Bothwell ALM; Jung SM; Song JJ; Park YB; Lee SW
Lupus; 2018 Apr; 27(5):771-779. PubMed ID: 29233037
[TBL] [Abstract][Full Text] [Related]
15. Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection.
Liu KT; Liu YH; Chen YH; Lin CY; Huang CH; Yen MC; Kuo PL
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240351
[TBL] [Abstract][Full Text] [Related]
16. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum BAFF levels in patients with autoimmune hepatitis.
Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580
[TBL] [Abstract][Full Text] [Related]
18. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis.
Yu Z; Nian C; Sun W; Liu X; Nian X
Clin Chim Acta; 2024 Jun; 559():119682. PubMed ID: 38643819
[TBL] [Abstract][Full Text] [Related]
20. Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C.
Nakamura K; Yoneda M; Takamoto S; Nakade Y; Yokohama S; Tamori K; Aso K; Matui T; Sato Y; Aoshima M; Makino I
J Gastroenterol Hepatol; 1999 May; 14(5):413-8. PubMed ID: 10355503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]